Page last updated: 2024-09-02

fingolimod hydrochloride and Auricular Fibrillation

fingolimod hydrochloride has been researched along with Auricular Fibrillation in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Damoiseaux, J; Hupperts, R; Muris, AH; Rolf, L; van Daele, M	1
D'Onghia, M; Direnzo, V; Manni, A; Paolicelli, D; Tortorella, C; Trojano, M; Zoccolella, S	1
Chabwine, JN; Démonet, JF; du Pasquier, RA; Hirt, L; Kuntzer, T; Michel, P; Rossetti, AR; Schluep, M; Vingerhoets, FG	1
Cocco, G	1
Hunt, TL; Kovarik, JM; Maton, S; Neddermann, D; Riviere, GJ; Schmouder, RL	1

Trials

1 trial(s) available for fingolimod hydrochloride and Auricular Fibrillation

Article	Year
A mechanistic study to assess whether isoproterenol can reverse the negative chronotropic effect of fingolimod. Journal of clinical pharmacology, 2008, Volume: 48, Issue:3 Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Area Under Curve; Atrial Fibrillation; Bradycardia; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Fingolimod Hydrochloride; Heart Rate; Humans; Infusions, Intravenous; Isoproterenol; Male; Patient Dropouts; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Tachycardia; Time Factors	2008

Article

Year

A mechanistic study to assess whether isoproterenol can reverse the negative chronotropic effect of fingolimod.

Journal of clinical pharmacology, 2008, Volume: 48, Issue:3

Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Area Under Curve; Atrial Fibrillation; Bradycardia; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Fingolimod Hydrochloride; Heart Rate; Humans; Infusions, Intravenous; Isoproterenol; Male; Patient Dropouts; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Tachycardia; Time Factors

2008

Other Studies

4 other study(ies) available for fingolimod hydrochloride and Auricular Fibrillation

Article	Year
Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment. Neurology, 2014, Mar-18, Volume: 82, Issue:11 Topics: Adult; Atrial Fibrillation; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; Propylene Glycols; Sphingosine	2014
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study. Journal of clinical pharmacology, 2015, Volume: 55, Issue:10 Topics: Adult; Atrial Fibrillation; Atrioventricular Block; Blood Pressure; Electrocardiography; Female; Fingolimod Hydrochloride; Heart; Heart Rate; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Product Surveillance, Postmarketing	2015
[Neurology]. Revue medicale suisse, 2012, Jan-11, Volume: 8, Issue:323 Topics: Antibodies, Monoclonal; Anticonvulsants; Atrial Fibrillation; Carbamates; Chronic Disease; Deep Brain Stimulation; Dopamine Agonists; Epilepsy; Fingolimod Hydrochloride; Genetic Therapy; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Multiple Sclerosis; Muscular Diseases; Neurology; Parkinson Disease; Phenylenediamines; Polyneuropathies; Propylene Glycols; Sphingosine; Stroke; Treatment Outcome; Valproic Acid	2012
A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart? Cardiovascular toxicology, 2012, Volume: 12, Issue:3 Topics: Arthritis, Psoriatic; Atrial Fibrillation; Autoimmune Diseases; Celecoxib; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Factor V; Fingolimod Hydrochloride; Heart; Heart Diseases; Heart Failure; Humans; Hypertension; Immunosuppressive Agents; Male; Middle Aged; Mitral Valve Insufficiency; Multiple Sclerosis; Mutation; Myocardium; Propylene Glycols; Pyrazoles; Sjogren's Syndrome; Sphingosine; Sulfonamides	2012